Cornelia Marty
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 4
- Advanced biosensing and bioanalysis techniques 2
- Angiogenesis and VEGF in Cancer 2
- Glycosylation and Glycoproteins Research 2
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Reto A. Schwendener (9 shared papers)Kurt Ballmer‐Hofer (8 shared papers)B Odermatt (2 shared papers)Carlos Garcı́a-Echeverrı́a (1 shared paper)Francis C. Szoka (1 shared paper)Herbert Schott (3 shared papers)Rom E. Eliaz (1 shared paper)Shlomo Nir (1 shared paper)
- Journals
- British Journal of Cancer (2 papers)Oncology Reports (1 paper)Cancer Letters (1 paper)Journal of Biological Chemistry (1 paper)Cellular and Molecular Life Sciences (1 paper)
- Partner nations
- SwitzerlandGermanyIsrael
In The Last Decade
Cornelia Marty
12 papers receiving 1.3k citations
Cornelia Marty's Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 465
- Biomaterials 208
- Molecular Biology 825
- Oncology 284
- Microbiology 62
Countries citing papers authored by Cornelia Marty
This map shows the geographic impact of Cornelia Marty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Marty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Marty more than expected).
Fields of papers citing papers by Cornelia Marty
This network shows the impact of papers produced by Cornelia Marty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Marty. The network helps show where Cornelia Marty may publish in the future.
Co-authors
The 20 scholars most cited alongside Cornelia Marty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach Hit paper breakdown → | 2006 | 502 |
| 2 | 2003 | 351 | |
| 3 | 2004 | 127 | |
| 4 | 2004 | 93 | |
| 5 | 2005 | 73 | |
| 6 | 2002 | 58 | |
| 7 | 2005 | 32 | |
| 8 | 2001 | 30 | |
| 9 | 2004 | 24 | |
| 10 | Metastases of human tumor xenografts in nude mice. | 1984 | 18 |
| 11 | Targeting human cancer cells with VEGF receptor-2-directed liposomes. | 2005 | 16 |
| 12 | 2007 | 11 |
About Cornelia Marty
Cornelia Marty is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Biomaterials, Immunology and Oncology, having authored 12 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cell Adhesion Molecules Research (2 papers), Virus-based gene therapy research (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Immunology (465 citations), Biomaterials (208 citations), Molecular Biology (825 citations), Oncology (284 citations) and Microbiology (62 citations). Cornelia Marty has collaborated with scholars based in Switzerland, Germany and Israel. Frequent co-authors include Reto A. Schwendener, Kurt Ballmer‐Hofer, B Odermatt, Carlos Garcı́a-Echeverrı́a, Francis C. Szoka, Herbert Schott, Rom E. Eliaz, Shlomo Nir, R Klemenz and Annabelle Renard. Their work appears in journals such as British Journal of Cancer, Oncology Reports, Cancer Letters, Journal of Biological Chemistry and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.